Join us in November to hear about steriles manufacturing best practices from our expert
Sterile drug products, also referred to as injectables, parenterals or aseptics, make up 40% of all small molecule drugs currently in development and are expected to grow more than 50% by 2028. For many drug developers, a sterile drug product is the best and possibly only delivery mechanism for their molecule. However, navigating the development, analytical and new regulatory requirements for these types of drugs can be very complicated, requiring specialized expertise and dedicated facilities in order to ensure a successful on-time program delivery.
In this upcoming webinar, Dr. Gareth Jenkins will discuss sterile product development using customer case studies to demonstrate how an integrated manufacturing and clinical testing approach to sterile product development can dramatically reduce development risks, shorten timelines and improve the chances of success.
Please register your interest using the form below for one of our three dates:
- Tuesday, November 14th at 12pm GMT / 7:00am EST / 5:00am PST
- Wednesday, November 15th at 11:30am EST / 16:30pm GMT / 8:30am PST
- Thursday, November 16th at 11:30am PST / 18:30pm GMT / 14:30pm EST
Register today
Key Topics
- How integrated program delivery can for sterile drug products accelerate development timelines
- How single-use systems eliminate the need for excipient compatibility and reduce risk
- How in-house microbiology can cut out white space and streamline product delivery
About Dr. Gareth Jenkins
Dr. Gareth Jenkins has over 25 years of experience in the pharmaceutical services industry spanning and holds a degree and PhD in Organic Chemistry from Imperial College, London, and an MBA in Entrepreneurship from Manchester Business School. He is also a Fellow of the Royal Society of Chemistry.
More Insight: Chemistry Today Panel Discussion on Flow Chemistry
Read Gareth Jenkins' contribution from a panel discussion with Chemistry Today, July/August 2022 issue, on topics including:
- The typical scale in which continuous manufacturing processes are carried out at Quotient Sciences
- Advantages of implementing process analytical technology (PAT) and artificial intelligence (AI)-assisted methods in flow compared with batch
- The importance of collaboration for the purpose of knowledge transfer and expanding skillsets in flow chemistry